Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: blood pressure variability measured by ambulatory 24-hour blood pressure monitoring.
- Who it may be relevant to
- Registry conditions: Ischemic Cerebrovascular Disease, Blood Pressure Variability. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study is a single-center prospective cohort of patients with ischemic cerebrovascular disease (ICVD) who have not met the diagnostic criteria for hypertension. Ambulatory 24-hour blood pressure monitoring (ABPM) will be performed at baseline and one year after the enrollment. The primary purpose of the study is to delineate the relationship of blood pressure variability (BPV) with the risk of composite vascular events in non-hypertensive patients with ICVD. The factors related to BPV, as well as the potential modulators of the associations between BPV and vascular risk, will be further explored among these patients.
Detailed description
Hypertension is one of the most important risk factors of ischemic cerebrovascular disease (ICVD), while various blood pressure variability (BPV) indices are immerging as novel prognostic indicators independent of the blood pressure level. However, the BPV profiles without hypertension have not been specifically observed. Considering the great importance of blood pressure management in ICVD, more research is needed to clarify whether and how BPV will increase the vascular risk in non-hypertensive patients with ICVD. This prospective cohort study will be helpful to invoke an early management of blood pressure in patients with ICVD before the clinical establishment of hypertension.
All eligible non-hypertensive patients hospitalized for ICVD will be consecutively enrolled in this cohort. Blood pressure measurements are obtained with ambulatory 24-hour blood pressure monitoring (ABPM) every 20 minutes during day-time (6:00-22:00) and every 30 minutes during night-time (22:00-6:00) at baseline and one year after the enrollment. The clinical, imaging and laboratory information will be collected at baseline. During an estimated 3-year follow-up, the vessel-related diagnostic or monitoring procedures, treatment, functional status and new vascular events will be recorded by web-based patients' self-reports and investigators' regular telephone visits.
Interventions
- Diagnostic test blood pressure variability measured by ambulatory 24-hour blood pressure monitoring
The ambulatory 24-hour blood pressure monitoring will be performed at baseline and one year after the enrollment. Various blood pressure variability characteristics will be obtained from these examinations.
Primary outcome measures
- 3-year risk of Major Adverse Cardiovascular Event [Time frame: 3 years]
Secondary outcome measures (8)
- 90-day Functional Outcome [Time frame: 90 days]
- 1-year rate of Major Adverse Cardiovascular Event [Time frame: 1 year]
- 1-year rate of Ischemic Stroke [Time frame: 1 year]
- 1-year rate of Acute Coronary Syndrome [Time frame: 1 year]
- 1-year rate of Cardiovascular Mortality [Time frame: 1 year]
- 3-year risk of Ischemic Stroke [Time frame: 3 years]
- 3-year risk of Acute Coronary Syndrome [Time frame: 3 years]
- 3-year risk of Cardiovascular Mortality [Time frame: 3 years]
Eligibility criteria
Inclusion criteria
- Diagnosed as ischemic stroke or transient ischemic attack (TIA), with confirmation of computed tomography or magnetic resonance imaging.
- Less than 90 days after onset of ischemic stroke or TIA symptoms.
- The blood pressure measured 5\~90 days after the ICVD onset without any anti-hypertension treatment is less than 140/90 mmHg (an average of ≥2 readings obtained on ≥ 2 occasions after emptying bladder, relaxing for more than 5 min, and avoiding caffeine, exercise, or smoking for at least 30 min before measurement).
- Consent to participate in the study.
Exclusion criteria
- A definite diagnosis of hypertension.
- Under anti-hypertension treatment.
- Worsening neurological conditions.
- With a National Institute of Health Stroke Scale score more than 5 points.
- Intracranial hemorrhage.
- Autonomic failure.
- With malignant tumors or poor organ functions or hematologic diseases, whose estimated life expectancy is less than 3 years.
- With contraindications to ambulatory 24-hour blood pressure monitoring or fail to finish the examination at baseline.
- Mental disease.
- Pregnant.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Xuanwu Hospital, Capital Medical University — Beijing
Identifiers
NCT: NCT05232240 · BPV-NhICVD